Envoy Medical (COCH) Change in Receivables (2022 - 2026)
Envoy Medical (COCH) reported Change in Receivables of -$3000.0 for Q1 2026, down 175.0% on a YoY basis from $4000.0 in Q1 2025, and down 200.0% sequentially from -$1000.0 in Q4 2025.
Envoy Medical (COCH) Change in Receivables (2022 - 2026) Analysis & Trends
Envoy Medical (COCH) has 5 years of Change in Receivables data on file, last reported at -$3000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables fell 175.0% year-over-year to -$3000.0; the trailing twelve-month figure through Mar 2026 stood at -$11000.0 (up 92.52% YoY), and the FY2025 full-year result was -$4000.0, up 87.5% from the prior year.
- Change in Receivables slipped to -$3000.0 in Q1 2026, from -$1000.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $119000.0 in Q1 2024 to a low of -$159000.0 in Q4 2024.
- A 5-year average of -$4714.3 and a median of -$2000.0 in 2025 frame the typical range for Change in Receivables.
- Peak annual rise in Change in Receivables reached 525.0% in 2024, while the deepest fall reached 307.69% in 2024.
- Tracing COCH's Change in Receivables over 5 years: stood at -$56000.0 in 2022, then soared by 30.36% to -$39000.0 in 2023, then sank by 307.69% to -$159000.0 in 2024, then soared by 99.37% to -$1000.0 in 2025, then tumbled by 200.0% to -$3000.0 in 2026.
- Business Quant data shows COCH's Change in Receivables at -$3000.0 in Q1 2026, -$1000.0 in Q4 2025, and -$8000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Envoy Medical | 45.50 Mn | 20.25 Mn | -274,000.00 | -3,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,000.00 |
| Mar 31, 2026 | -3,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Sep 30, 2025 | -8,000.00 |
| Sep 30, 2025 | -8,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Dec 31, 2024 | -159,000.00 |
| Dec 31, 2024 | -159,000.00 |
| Sep 30, 2024 | 23,000.00 |
| Sep 30, 2024 | 23,000.00 |
| Jun 30, 2024 | -15,000.00 |
| Jun 30, 2024 | -15,000.00 |
| Mar 31, 2024 | 119,000.00 |
| Mar 31, 2024 | 119,000.00 |
| Dec 31, 2023 | -39,000.00 |
| Dec 31, 2023 | -39,000.00 |